Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01234402
What this trial is testing

Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients

Who this might be right for
Breast Cancer
Eli Lilly and Company 153
Testing effectiveness (Phase 2)Study completedNCT00192101
What this trial is testing

Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 100
Early research (Phase 1)Ended earlyNCT02964507
What this trial is testing

Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer

Who this might be right for
Neoplasms
GlaxoSmithKline 124
Testing effectiveness (Phase 2)Study completedNCT02756364
What this trial is testing

Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy

Who this might be right for
Breast Neoplasms
Calithera Biosciences, Inc 141
Testing effectiveness (Phase 2)Study completedNCT02860000
What this trial is testing

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

Who this might be right for
Estrogen Receptor StatusHER2/Neu NegativeInvasive Breast Carcinoma+6 more
Mayo Clinic 96
Not applicableLooking for participantsNCT02338167
What this trial is testing

Praegnant Breast Cancer: Early/Advanced/Metastatic

Who this might be right for
Advanced/Metastatic Breast CancerBreast Cancer (Early Breast Cancer)
University Hospital Tuebingen 13,500
Testing effectiveness (Phase 2)Study completedNCT02664103
What this trial is testing

Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sanofi 2
Early research (Phase 1)WithdrawnNCT05634954
What this trial is testing

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
GE Healthcare
Large-scale testing (Phase 3)Study completedNCT01626222
What this trial is testing

4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 301
Testing effectiveness (Phase 2)Study completedNCT03045653
What this trial is testing

Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sun Yat-sen University 30
Early research (Phase 1)Ended earlyNCT01876251
What this trial is testing

A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Pfizer 30
Early research (Phase 1)Looking for participantsNCT05304962
What this trial is testing

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Regor Pharmaceuticals Inc. 64
Testing effectiveness (Phase 2)UnknownNCT06598046
What this trial is testing

A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

Who this might be right for
Metastatic Breast Cancer
Henan Cancer Hospital 48
Testing effectiveness (Phase 2)Study completedNCT00062686
What this trial is testing

GW572016 For Treatment Of Refractory Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 200
Testing effectiveness (Phase 2)Ended earlyNCT00934895
What this trial is testing

Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 27
Large-scale testing (Phase 3)Looking for participantsNCT05894239
What this trial is testing

Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 230
Early research (Phase 1)Study completedNCT05052437
What this trial is testing

PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer

Who this might be right for
Advanced and Metastatic Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 16
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Early research (Phase 1)Study completedNCT01676753
What this trial is testing

Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer

Who this might be right for
Advanced or Metastatic Breast CancerTriple Negative Breast Cancer
Jo Chien 32
Early research (Phase 1)Ended earlyNCT01199367
What this trial is testing

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Kyowa Kirin Co., Ltd. 11
Next Page